CV THERAPEUTICS, INC. (CVTX)

Healthcare: Biotechnology

Brokerage Ratings
Closing price on 09/30/2009: $0.00
Filers holding this stock on 09/30/2009: 0
Aggregate shares on 09/30/2009: 0
Aggregate shares on 06/30/2009: 976,552
Percent change: -100.000000%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
3
Neutral:
2
Negative:
2
Brokerage Date Issued Rating Price Target
BENCHMARK 02/23/2009 BUY $18.00
LEERINK SWANN 02/22/2009 MKT PERFORM $14.00
CITIGROUP 11/09/2008 SELL
CANTOR FITZGERALD 10/06/2008 BUY $42.00
NEEDHAM & CO 07/31/2007 HOLD
FIRST ALBANY 04/25/2007 BUY
DEUTSCHE SECURITIES 03/26/2007 SELL
Schedule 13d filings involving this stock
Filing Company Subject Company Date of Filing
View Amended Schedule 13D THIRD POINT LLC CV THERAPEUTICS, INC. 02/29/2008
View Amended Schedule 13D THIRD POINT LLC CV THERAPEUTICS, INC. 02/29/2008
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
08/13/2008
BLACKBURN BRENT K
 0 View Filing
09/09/2008
BLACKBURN BRENT K
 0 View Filing
08/27/2008
BLACKBURN BRENT K
 0 View Filing
11/06/2008
BLACKBURN BRENT K
 0 View Filing
11/20/2008
STUART LEWIS J
 0 View Filing
01/07/2009
BLACKBURN BRENT K
 0 View Filing
02/06/2009
BLACKBURN BRENT K
 0 View Filing